Your browser doesn't support javascript.
loading
High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma.
Chu, Gerard J; Linton, Anthony; Kao, Steven; Klebe, Sonja; Adelstein, Stephen; Yeo, Dannel; Rasko, John E J; Cooper, Wendy A.
Afiliação
  • Chu GJ; Gene and Stem Cell Therapy Program Centenary Institute, University of Sydney, Sydney, NSW, Australia.
  • Linton A; Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Kao S; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Klebe S; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Adelstein S; Department of Medical Oncology, Concord Hospital, Concord, NSW, Australia.
  • Yeo D; Asbestos Diseases Research Institute, Concord, NSW, Australia.
  • Rasko JEJ; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Cooper WA; Asbestos Diseases Research Institute, Concord, NSW, Australia.
Histopathology ; 83(2): 202-210, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37040900
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Receptores de Antígenos Quiméricos / Mesotelioma Maligno / Mesotelioma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Receptores de Antígenos Quiméricos / Mesotelioma Maligno / Mesotelioma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article